$ANKM
Ankam, Inc.

2022 Q3 Form 10-Q Financial Statement

#000178162922000023 Filed on September 30, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $561.00
YoY Change
% of Gross Profit
Operating Expenses $8.784K $6.542K $10.07K
YoY Change 70.73% 34.19%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$8.784K $6.542K $10.07K
YoY Change 70.73% 34.19%
Income Tax
% Of Pretax Income
Net Earnings -$8.784K -$6.542K -$10.07K
YoY Change 34.19%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 4.328M shares 4.258M shares 3.223M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.151K $7.692K $19.82K
Short-Term Investments
Other Short-Term Assets $212.3K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.151K $164.5K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $212.3K $60.61K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $4.151K $164.5K
Total Long-Term Assets $212.3K $60.61K
Total Assets $216.4K $225.1K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $92.60K $167.5K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $232.7K $232.6K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $232.7K $232.6K
Total Long-Term Liabilities
Total Liabilities $232.7K $232.6K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $51.84K $43.06K
YoY Change
Common Stock $4.328K $4.328K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$16.25K -$7.470K -$4.258K
YoY Change
Total Liabilities & Shareholders Equity $216.4K $225.1K
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$8.784K -$6.542K -$10.07K
YoY Change 34.19%
Depreciation, Depletion And Amortization $561.00
YoY Change
Cash From Operating Activities $16.08K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $35.02K
YoY Change
NET CHANGE
Cash From Operating Activities $16.08K
Cash From Investing Activities
Cash From Financing Activities $35.02K
Net Change In Cash $18.94K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $16.08K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001781629
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2021Q4 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
CY2021Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2021Q3 us-gaap Amortization And Depreciation Of Decontaminating And Decommissioning Assets
AmortizationAndDepreciationOfDecontaminatingAndDecommissioningAssets
usd
us-gaap Amortization And Depreciation Of Decontaminating And Decommissioning Assets
AmortizationAndDepreciationOfDecontaminatingAndDecommissioningAssets
usd
CY2022Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2021Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
usd
us-gaap Increase Decrease Due From Officers And Stockholders
IncreaseDecreaseDueFromOfficersAndStockholders
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
usd
CY2021 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-255392
dei Entity Registrant Name
EntityRegistrantName
ANKAM INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1900749
dei Entity Address Address Line1
EntityAddressAddressLine1
5348 Vegas Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89108
dei City Area Code
CityAreaCode
995
dei Local Phone Number
LocalPhoneNumber
599420389
dei Contact Personnel Email Address
ContactPersonnelEmailAddress
[email protected]
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4327996 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4151 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
877 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3265 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
4151 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4142 usd
CY2022Q3 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
134810 usd
CY2022Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
77469 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6735 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
212279 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6735 usd
CY2022Q3 us-gaap Assets
Assets
216430 usd
CY2021Q4 us-gaap Assets
Assets
10877 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
92599 usd
CY2022Q3 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
140085 usd
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
34072 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
232684 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34072 usd
CY2022Q3 us-gaap Liabilities
Liabilities
232684 usd
CY2021Q4 us-gaap Liabilities
Liabilities
34072 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4327996 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4327996 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3250000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3250000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
4328 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3250 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31262 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
51844 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
26445 usd
CY2022Q3 us-gaap Receivable From Officers And Directors For Issuance Of Capital Stock
ReceivableFromOfficersAndDirectorsForIssuanceOfCapitalStock
16254 usd
CY2021Q4 us-gaap Receivable From Officers And Directors For Issuance Of Capital Stock
ReceivableFromOfficersAndDirectorsForIssuanceOfCapitalStock
23195 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
216430 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10877 usd
CY2022Q3 us-gaap Amortization And Depreciation Of Decontaminating And Decommissioning Assets
AmortizationAndDepreciationOfDecontaminatingAndDecommissioningAssets
5144 usd
us-gaap Amortization And Depreciation Of Decontaminating And Decommissioning Assets
AmortizationAndDepreciationOfDecontaminatingAndDecommissioningAssets
6266 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
906 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4730 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1152 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
3635 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
4239 usd
us-gaap Professional Fees
ProfessionalFees
14403 usd
us-gaap Professional Fees
ProfessionalFees
13939 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
8784 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5145 usd
us-gaap Operating Expenses
OperatingExpenses
25399 usd
us-gaap Operating Expenses
OperatingExpenses
15091 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-8784 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5145 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-25399 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-15091 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8784 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5145 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-25399 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-15091 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4327996 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3250000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4004149 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3250000 shares
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
3250000 usd
CY2020Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
-5188 usd
CY2021Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
3250 shares
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5071 usd
CY2021Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
3250000 usd
CY2021Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
-7009 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4875 usd
CY2021Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
3250000 usd
CY2021Q2 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
-11884 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5145 usd
CY2021Q3 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
3250000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-17029 usd
CY2021Q4 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
3250000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
-23195 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
29010 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10073 usd
CY2022Q1 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
4217000 usd
CY2022Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
-4258 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3330 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6542 usd
CY2022Q2 us-gaap Shares Issued
SharesIssued
4327996 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-7470 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8784 usd
CY2022Q3 us-gaap Shares Issued
SharesIssued
4327996 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-16254 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-25399 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15091 usd
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
6266 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3265 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-97 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
134810 usd
us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
77000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
92599 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
800 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
135079 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14388 usd
us-gaap Increase Decrease Due From Officers And Stockholders
IncreaseDecreaseDueFromOfficersAndStockholders
3250 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32340 usd
us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
106013 usd
us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
15200 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
138353 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18450 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3274 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4062 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
877 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4151 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4246 usd
us-gaap Revenue Recognition Allowances
RevenueRecognitionAllowances
<p id="xdx_84A_eus-gaap--RevenueRecognitionAllowances_z8neY7mnjEJe" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_86E_zHCZSvVxKBza">Revenue Recognition</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) No. 2014-09, <i>"Revenue from Contracts with Customer"</i>. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognizes as it fulfills its obligations under reach of its agreements:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 1: Identify the contract with a customer</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 2: Identify the performance obligations in the contract</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 3: Determine the transaction price</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 4: Allocate the transaction price to the performance obligations in the contract</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_znWDUlQf1S56" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_865_zVL12r659x6h">Use of Estimates</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
51844 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
26445 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
51844 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
26445 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
10887 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5553 usd
CY2022Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
10887 usd
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
5553 usd
CY2022Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
51844 usd

Files In Submission

Name View Source Status
0001781629-22-000023-index-headers.html Edgar Link pending
0001781629-22-000023-index.html Edgar Link pending
0001781629-22-000023.txt Edgar Link pending
0001781629-22-000023-xbrl.zip Edgar Link pending
exh31.htm Edgar Link pending
exh32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q_ank.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20220831.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20220831_cal.xml Edgar Link unprocessable
none-20220831_lab.xml Edgar Link unprocessable
none-20220831_pre.xml Edgar Link unprocessable
form10q_ank_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
none-20220831_def.xml Edgar Link unprocessable